The N3-methylcytidine (m3C) gene, METTL2A, is highly expressed in breast invasive carcinoma (BRCA), and differential analysis showed that METTL2A was differentially expressed in cancer and paracancerous tissues more strongly than METTL6 and METTL8. Here, METTL2A is linked to cancer.